Chris Picardo

Director/Miembro de la Junta en Modulus Therapeutics, Inc. .

Consumer Services

Commercial Services

Perfil

Chris Picardo is currently working as a Director at Life Science Washington and Modulus Therapeutics, Inc. He completed his undergraduate degree from Williams College.

Cargos activos de Chris Picardo

Empresas	Cargo	Inicio
Modulus Therapeutics, Inc. Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020.	Director/Miembro de la Junta	-
Life Science Washington	Director/Miembro de la Junta	11/01/2022

Todos los cargos activos de Chris Picardo

Formación de Chris Picardo.

Williams College

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Chris Picardo.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Life Science Washington
Modulus Therapeutics, Inc. Modulus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Modulus Therapeutics, Inc. is a company dedicated to discovering cell therapy solutions for patients. The company is based in Seattle, WA. The company uses rapid prototyping and generative design to accelerate discovery and optimize cell therapies to meet therapeutic design goals. The company's platform offers a unique opportunity to leverage machine learning to maximize efficacy through modular design. Modulus envisions a world where cancer is no longer a life-threatening disease, and they are dedicated to transforming the future of cancer therapy through design-driven therapeutics. Modulus Therapeutics was founded in 2020 by Max Darnell and Bryce Daines. Max Darnell has been the CEO since 2020.	Commercial Services